======= NEU3 =======
== Gene Information ==
* **Official Symbol**: NEU3
* **Official Name**: neuraminidase 3
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10825|10825]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9UQ49|Q9UQ49]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=NEU3&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NEU3|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/604617|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Plays a role in modulating the ganglioside content of the lipid bilayer at the level of membrane-bound sialyl glycoconjugates. {ECO:0000269|PubMed:10861246, ECO:0000269|PubMed:20511247}.
No Pfam Domain information is available for this gene.
|alpha-sialidase activity|
|exo-alpha-(2->8)-sialidase activity|
|exo-alpha-(2->6)-sialidase activity|
|exo-alpha-sialidase activity|
|exo-alpha-(2->3)-sialidase activity|
|ganglioside catabolic process|
|oligosaccharide catabolic process|
|glycosphingolipid catabolic process|
|glycolipid catabolic process|
|ceramide catabolic process|
|ganglioside metabolic process|
|sphingolipid catabolic process|
|membrane lipid catabolic process|
|oligosaccharide metabolic process|
|glycosphingolipid metabolic process|
|ceramide metabolic process|
|glycolipid metabolic process|
|liposaccharide metabolic process|
|carbohydrate catabolic process|
|sphingolipid metabolic process|
|carbohydrate derivative catabolic process|
|cellular lipid catabolic process|
|membrane lipid metabolic process|
|lipid catabolic process|
|carbohydrate metabolic process|
|intracellular membrane-bounded organelle|
|cellular amide metabolic process|
|cellular lipid metabolic process|
|carbohydrate derivative metabolic process|
|organonitrogen compound catabolic process|
|lipid metabolic process|
|organic substance catabolic process|
|cellular catabolic process|
|membrane|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp346|CoCl2 18μM R07 exp346]]|-2.13|
|[[:results:exp48|Mubritinib 0.2μM R01 exp48]]|-1.89|
|[[:results:exp54|Taxol 0.002μM R01 exp54]]|-1.78|
|[[:results:exp47|Lapatinib 5μM R01 exp47]]|-1.74|
|[[:results:exp430|Rifampicin 30μM R08 exp430]]|-1.71|
^Gene^Correlation^
|[[:human genes:h:hgc6.3|HGC6.3]]|0.563|
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 8279
* **Expression level (log2 read counts)**: 6.86
{{:chemogenomics:nalm6 dist.png?nolink |}}